SCHEMBL7243233

SCHEMBL7243233

O=C(O)C=CC(SCCCN1CCOCC1)c1ccc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.49
AURKA O14965 3/20 0.48
AURKB Q96GD4 3/20 0.48
SRC P12931 2/20 0.47
MAP2K1 Q02750 2/20 0.47
ROCK2 O75116 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
RET P07949 1/20 0.47
MET P08581 1/20 0.47
MAPT P10636 1/20 0.47
PDGFRA P16234 1/20 0.47
LTK P29376 1/20 0.47
TTK P33981 1/20 0.47
KDR P35968 1/20 0.47
MAP2K2 P36507 1/20 0.47
BTK Q06187 1/20 0.47
TYRO3 Q06418 1/20 0.47
TNK2 Q07912 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7241603 0.92 EGFR (0.56) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7122290 0.84 EGFR (0.47) EGFRERBB2ERBB4
SCHEMBL7124574 0.83 EGFR (0.46) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7236735 0.83 EGFR (0.48) EGFRAURKBSRCMAP2K1LCK
SCHEMBL7243231 0.81 AURKA (0.52) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7240179 0.80 EGFR (0.57) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7240175 0.80 EGFR (0.57) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7233111 0.79 EGFR (0.60) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7243237 0.78 AURKA (0.51) EGFRAURKAAURKBSRCMAP2K1
SCHEMBL7243230 0.78 AURKA (0.51) EGFRAURKAAURKBSRCMAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
US-6562818-B1 For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis WARNER-LAMBERT COMPANY 2003-05-13 US disclosed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US disclosed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed